HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Autosomal Dominant Polycystic Kidney Disease in which the Polycystic Liver Volume Was Reduced by Rigorous Blood Pressure Control.

Abstract
Polycystic liver disease (PLD) is the most common extrarenal manifestation of autosomal dominant polycystic kidney disease (ADPKD). However, current treatments for PLD are only supportive. We experienced a case of enlarged kidneys and liver in a 53-year-old Japanese man with ADPKD who was on hemodialysis. He underwent renal transcatheter arterial embolization (TAE) for enlarged kidneys. His blood pressure (BP) decreased after renal TAE, and his liver volume decreased from 5,259 mL to 4,647 mL (11.6% reduction) within 1 year after renal TAE. This case suggests that rigorous blood pressure control may be beneficial for ameliorating enlarged PLD.
AuthorsTatsuya Suwabe, Yoshifumi Ubara, Daisuke Ikuma, Hiroki Mizuno, Noriko Hayami, Masayuki Yamanouchi, Naoki Sawa
JournalInternal medicine (Tokyo, Japan) (Intern Med) Vol. 61 Issue 1 Pg. 49-52 (Jan 01 2022) ISSN: 1349-7235 [Electronic] Japan
PMID34219109 (Publication Type: Case Reports, Journal Article)
Topics
  • Blood Pressure
  • Cysts (diagnostic imaging)
  • Humans
  • Kidney (diagnostic imaging)
  • Liver Diseases (diagnostic imaging, therapy)
  • Male
  • Middle Aged
  • Polycystic Kidney, Autosomal Dominant (complications, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: